MYWOT
Child safety
Confidence
Trustworthiness
Confidence
MALICIOUS CONTENT INDICATORS
Cristaltherapeutics.com most likely does not offer any malicious content.
Secure connection support
HTTPS
Cristaltherapeutics.com provides SSL-encrypted connection.
ADULT CONTENT INDICATORS
Cristaltherapeutics.com most likely does not offer any adult content.
Popular pages
-
About us - Cristal Therapeutics
Cristal Therapeutics offers CliCr: a powerful copper-free click chemistry reagent that meets all demands of the life science industry.
-
Cristal Therapeutics and Intravacc Announce Strategic Collaboration to Advance Novel Vaccine
First joint CriVac® vaccine candidate to target receptor-binding domain of SARS-CoV-2 Evaluation of Cristal’s CliCr® and Intravacc’s OMV technology Bilthoven and Maastricht, the Netherlands, 6 January...
-
Investors - Cristal Therapeutics
An overview of the investors in Cristal Therapeutics.
-
About us - Cristal Therapeutics
About us Mission statement Cristal Therapeutics develops the next generation targeted nanomedicines to treat various diseases, in particular cancer. With CriPec ® nanomedicines Cristal Therapeutics ai...
-
New Data Opens Potential for Patient Stratification for CriPec® Nanomedicines in Cancer and Other
Maastricht, The Netherlands, 4 May 2022 – Cristal Therapeutics, a Dutch pharmaceutical company developing tailored nanomedicines for the treatment of cancer and other diseases with high unmet patient ...
-
News - Cristal Therapeutics
News 26th January 2023 As per 25 Jan 2023, Iris Biotech sells CliCr® and CliCr® reagents for non-GXP research purposes. For GXP applications, parties are to connect with Cristal Therapeutics. Read mor...